#United States #New York #Class Action #Gross Law Firm #Zenas BioPharma

Zenas BioPharma Investors: Class Action Lawsuit Notice and Next Steps

The Gross Law Firm has issued an important notification for investors of Zenas BioPharma, Inc. (NASDAQ: ZBIO). If you've acquired shares during the class period, you are encouraged to reach out to the firm regarding potential lead plaintiff appointment in a current class action lawsuit.

Overview of the Class Action Lawsuit

The lawsuit is aimed at those who purchased or obtained ZBIO’s securities in accordance with the registration statement and related prospectus released during the company's initial public offering (IPO) in September 2024. Allegedly, during this period, the company is accused of making materially false statements and failing to disclose critical information concerning its financial health.

Key Allegations

According to the complaint filed, Zenas BioPharma overstated its financial capabilities significantly. Specifically, the firm purportedly did not adequately disclose the amount of time it could fund operational activities with the current cash and expected proceeds from the IPO. As a result, statements made by the defendants are claimed to have been misleading and negligently prepared at every relevant point in time.

Important Deadlines

Shareholders who wish to participate in this class action have a deadline fast approaching. The last day to seek the lead plaintiff position is June 16, 2025. It is crucial for affected shareholders to register promptly to protect their rights and potential recovery.

How to Register

To register as a participant in the class action lawsuit, interested shareholders can submit their information through the designated registration link. This registration allows you to receive updates via a monitoring software that tracks the progress of the case. Participation in the case incurs no costs, and you are not obligated to assume the lead plaintiff role to partake in any recovery.

Why Choose The Gross Law Firm?

The Gross Law Firm is a well-known class action law firm dedicated to safeguarding the rights of investors who have faced losses due to misrepresentation or fraudulent activities. With a commitment to ensuring corporate accountability, the firm tirelessly seeks financial recovery for those who have been harmed by misleading statements made by companies like Zenas BioPharma.

If you believe you may have a claim or want to understand your rights more thoroughly, contact The Gross Law Firm today. Their experienced team is ready to assist you in navigating this challenging situation.

Contact Information

• - Address: The Gross Law Firm, 15 West 38th Street, 12th Floor, New York, NY 10018
• - Email: info@grosslawfirm.com
• - Phone: (646) 453-8903

Stay informed and take action by participating in this class action lawsuit. Your rights as an investor matter, and timely registration can make all the difference.